Pharma patent cliff impedes production
The largest contributor to the fall in industrial output was the collapse of the basic pharmaceutical products and preparations which slumped 35.2%, dragging the whole index into negative territory.
PharmaChemical Ireland director Matt Moran said the sector is traditionally volatile but admitted that unless new products were found to replace the drugs that have come off patent, the sector will face problems.